By MIKE HALLMANMADOW, APU and SETH ELMANNIC, APMINS EditorThe new research from a University of Utah research team finds that patients who suffer from sinus hypertension may have more nasal contaminants than those who do not.
The study was published in the journal Medicine & Science in Sports & Exercise.
It found that nasal contamination of the nasal cavity was significantly higher in patients with sinus chronic obstructive pulmonary disease, or COPD, than those with chronic obstructory pulmonary disease or COPS, the authors wrote.
This suggests that patients with COPD may have higher levels of the bacteria, which can lead to nasal problems.
Dr. John Rau, a professor of medicine at UT, said the findings suggest that some patients may have to take more antibiotics or other drugs to avoid the disease.
Rau said the research suggests the importance of identifying and treating patients who are at high risk for nasal congestion.
He said nasal infections, including COPD and sinus inflammation, can be prevented or managed by following a plan to eliminate the environment in which bacteria thrive.
Rai said nasal congestion can be caused by a variety of factors, including asthma, allergies and other chronic conditions.
The research was conducted by researchers at UT’s School of Medicine, UT’s Center for Environmental Medicine and UT Health Sciences, and the Utah Health Science Center.
Dr Jennifer P. Johnson, a microbiologist who is the study’s lead author, said she hopes the study will provide patients with a better understanding of how their nasal flora may affect their health.
“The nasal microbiome is very important for health,” Johnson said.
“We have to understand what the nose microbiome is doing to our health, and how that can impact our health.”
The study also found that patients treated with nasal antibiotics have significantly higher levels, on average, of bacteria that are considered by the World Health Organization to be harmful to health, including MRSA and C. difficile.
“There are still some questions as to why we have these elevated levels of bacteria, and I’m hoping we can learn more about how we can make these antibiotics less harmful to our lungs,” Johnson, who is also the chief of the UT Department of Health, said.
Johnson said that while it is common for nasal infections to be difficult to treat, they can be life-threatening, particularly for patients who do have COPD.
“I think it’s really important to remember that we are just starting to understand the impact that the nose is having on our health,” she said.
In the study, the researchers compared nasal microbiomes of 613 patients with and without sinus congestion.
They compared these microbiomes to the microbiomes in the general population, which had been collected from a large population of patients.
They also analyzed a sample of nasal mucus.
The researchers found that a statistically significant number of nasal samples with nasal bacteria had been found to have lower levels of C.difficile and MRSA than those without nasal bacteria.
These samples had a lower mean weight of 1.1 gram per gram of mucus and were significantly more prevalent in the patients with nasal congestion, as well as in the nonsmoking group.
The nasal microbiome is thought to have an important role in preventing infection.
A person with COPS has a higher risk of acquiring nasal infections than does a person without COPD or other chronic health conditions.
Johnson said the finding of elevated nasal bacteria may indicate that patients may be more likely to develop nasal infections.
“This is just a small study,” Johnson added.
“But it’s a very good example of the way we’re trying to understand how the nasal microbiome affects the respiratory tract and the disease process in a patient.”
Rau, who was not involved in the study and was not a participant in the clinical trial, said that more studies are needed to find out if nasal congestion is a cause or effect of nasal disease.
“It’s not clear what is going on,” Rau said.
“We really need more studies.”
He said the study is important because it indicates that nasal bacteria can influence health.
The authors wrote that they were “surprised to find that the nasal microbiota was more likely than the general mucus microbiome to have higher concentrations of these bacteria in patients who were infected with COPDS.”
The authors did not address how the microbiome of patients with chronic respiratory disease is influenced by COPD treatment.
Johnson also said that nasal hygiene may be an important component in preventing infections and improving health.
She said that when it comes to the nasal environment, the microbiome is a very important factor.
“People should be looking for ways to eliminate it from the environment and to change the environment,” she added.